1. Home
  2. ATCH vs HBIO Comparison

ATCH vs HBIO Comparison

Compare ATCH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.25

Market Cap

39.2M

Sector

N/A

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.66

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
HBIO
Founded
2022
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
39.2M
33.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ATCH
HBIO
Price
$0.25
$0.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
4.2M
598.2K
Earning Date
02-18-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,303,120.00
$87,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.22
P/E Ratio
N/A
N/A
Revenue Growth
80.78
N/A
52 Week Low
$0.14
$0.28
52 Week High
$15.27
$2.28

Technical Indicators

Market Signals
Indicator
ATCH
HBIO
Relative Strength Index (RSI) 34.35 44.94
Support Level $0.25 $0.71
Resistance Level $0.27 $0.80
Average True Range (ATR) 0.02 0.05
MACD -0.00 -0.02
Stochastic Oscillator 0.89 6.90

Price Performance

Historical Comparison
ATCH
HBIO

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: